Preliminary experiments show conolidine may inhibit particular ion channels, decreasing neuronal excitability and limiting pain indicators. This system is particularly suitable in neuropathic agony, the place abnormal signaling leads to persistent distress. On top of that, conolidine seems to influence G protein-coupled receptor (GPCR) pathways int